New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? [electronic resource]
Producer: 20140626Description: 559-67 p. digitalISSN:- 1573-7241
- Animals
- Anticholesteremic Agents -- therapeutic use
- Apolipoproteins B -- metabolism
- Benzimidazoles -- therapeutic use
- Cholesterol, LDL -- metabolism
- Dyslipidemias -- drug therapy
- Humans
- Lipid Metabolism, Inborn Errors -- drug therapy
- Lipoprotein(a) -- metabolism
- Oligonucleotides -- therapeutic use
- Proprotein Convertase 9
- Proprotein Convertases -- antagonists & inhibitors
- Serine Endopeptidases
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.